• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Vγ4+γδT Cells Aggravate Severe H1N1 Influenza Virus Infection-Induced Acute Pulmonary Immunopathological Injury via Secreting Interleukin-17A

tetano

Editor, Senior Moderator
Front Immunol. 2017 Aug 31;8:1054. doi: 10.3389/fimmu.2017.01054. eCollection 2017.
[h=1]Vγ4+γδT Cells Aggravate Severe H1N1 Influenza Virus Infection-Induced Acute Pulmonary Immunopathological Injury via Secreting Interleukin-17A.[/h] Xue C[SUP]1[/SUP], Wen M[SUP]2[/SUP], Bao L[SUP]3[/SUP], Li H[SUP]4[/SUP], Li F[SUP]3[/SUP], Liu M[SUP]5[/SUP], Lv Q[SUP]3[/SUP], An Y[SUP]2[/SUP], Zhang X[SUP]2[/SUP], Cao B[SUP]4,[/SUP][SUP]6,[/SUP][SUP]7[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] The influenza A (H1N1) pdm09 virus remains a critical global health concern and causes high levels of morbidity and mortality. Severe acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are the major outcomes among severely infected patients. Our previous study found that interleukin (IL)-17A production by humans or mice infected with influenza A (H1N1) pdm09 substantially contributes to ALI and subsequent morbidity and mortality. However, the cell types responsible for IL-17A production during the early stage of severe influenza A (H1N1) pdm09 infection remained unknown. In this study, a mouse model of severe influenza A (H1N1) pdm09 infection was established. Our results show that, in the lungs of infected mice, the percentage of γδT cells, but not the percentages of CD4[SUP]+[/SUP]Th and CD8[SUP]+[/SUP]Tc cells, gradually increased and peaked at 3 days post-infection (dpi). Further analysis revealed that the Vγ4[SUP]+[/SUP]γδT subset, but not the Vγ1[SUP]+[/SUP]γδT subset, was significantly increased among the γδT cells. At 3 dpi, the virus induced significant increases in IL-17A in the bronchoalveolar lavage fluid (BALF) and serum. IL-17A was predominantly secreted by γδT cells (especially the Vγ4[SUP]+[/SUP]γδT subset), but not CD4[SUP]+[/SUP]Th and CD8[SUP]+[/SUP]Tc cells at the early stage of infection, and IL-1β and/or IL-23 were sufficient to induce IL-17A production by γδT cells. In addition to secreting IL-17A, γδT cells secreted interferon (IFN)-γ and expressed both an activation-associated molecule, natural killer group 2, member D (NKG2D), and an apoptosis-associated molecule, FasL. Depletion of γδT cells or the Vγ4[SUP]+[/SUP]γδT subset significantly rescued the virus-induced weight loss and improved the survival rate by decreasing IL-17A secretion and reducing immunopathological injury. This study demonstrated that, by secreting IL-17A, lung Vγ4[SUP]+[/SUP]γδT cells, at least, in part mediated influenza A (H1N1) pdm09-induced immunopathological injury. This mechanism might serve as a promising new target for the prevention and treatment of ALI induced by influenza A (H1N1) pdm09.


[h=4]KEYWORDS:[/h] A (H1N1) pdm09 virus; NKG2D; acute lung injury; influenza; interleukin-17A; γδT cell subsets

PMID: 28912779 PMCID: PMC5583159 DOI: 10.3389/fimmu.2017.01054
 
Back
Top Bottom